WHAT’S TRENDING
-
Innovation at BD
The Future and InnovationDiscover how we’re innovating to drive better outcomes for patients at critical moments throughout their livesLearn more
-
NEWS
BD Names Gregory J. Hayes to Board of DirectorsLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Gregory J. Hayes to its board of directors, effective March 26,...
-
NEWS
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision SurgeryLearn MoreBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the first patient treated in an Investigational Device Exemption (IDE) clinical trial...
-
News
Patterns of Bacterial ResistanceListen as BD thought leaders Dr. Gupta and Dr. Yu give insights into patterns of rising bacterial resistance at a Health Watch USA Meeting on May 19, 2022Learn more